What are the Top Pathogens Impacting CLABSI Infections in Hospitals


Get Personalized Hospital Specific Presentation on Unified AI Quality, Safety, Risk & Incident Software


This article is part of the Dexur Insight, which is focused on Hospital Quality and Safety topics and is read by CEOs, CMOs, CNOs, CQOs, Quality, Safety, Compliance, Analytics & Performance teams. Please email dexurqualitysights@dexur5.com to join this newsletter and receive updates (not more than once per week).

Importance and Background on CLABSI and Data Acquisition from Dexur

Central Line-Associated Bloodstream Infections (CLABSI) remain a significant challenge in healthcare settings, directly influencing patient outcomes and healthcare costs. CLABSI, a severe infection occurring in patients with central venous catheters, poses risks that extend beyond immediate health concerns, impacting hospital ratings and reimbursement rates.

Dexur, a critical player in healthcare data analytics, focuses on harnessing data to enhance safety and quality in healthcare institutions. The core of Dexur’s data acquisition strategy involves collecting information from hospitals that submit data to the Centers for Disease Control and Prevention’s National Healthcare Safety Network (NHSN). NHSN is the nation’s most widely used healthcare-associated infection tracking system, providing facilities, states, regions, and the nation with data needed to identify problem areas, measure progress of prevention efforts, and ultimately eliminate healthcare-associated infections.

Dexur’s analysis of this data aids hospitals in participating effectively in various safety and quality programs. These include the CMS Star Rating, which is a consumer-focused system evaluating hospital quality; the Hospital-Acquired Condition Reduction Program (HACRP), aimed at reducing conditions acquired in hospital settings; the Value-Based Purchasing (VBP) program, which incentivizes high-quality, efficient clinical care; and Leapfrog Hospital Safety Grades, a grading system that provides a comprehensive view of patient safety.

Through this data-centric approach, Dexur offers an in-depth understanding of CLABSI, enabling healthcare providers to not only track and benchmark their performance but also to engage in informed decision-making for performance improvement initiatives. This robust data framework serves as the foundation for exploring the pathogens significantly impacting CLABSI, a crucial step toward enhancing patient safety and healthcare quality.

Pathogens Impacting CLABSI

The role of specific pathogens contributing to CLABSI is critically important. Dexur's analysis, leveraging data submitted by hospitals to the CDC's NHSN, has identified vital pathogens that significantly contribute to CLABSI incidences. Among more than 80 identified pathogens, five are frequently associated with CLABSI infections in hospitals. These are:

Understanding the landscape of CLABSI infections hinges on the crucial identification of these pathogens. Each pathogen presents unique challenges in treatment and prevention, necessitating their thorough study and monitoring as integral components of hospital infection control and patient safety strategies. Dexur's continuous analysis and benchmarking of pathogen-related data empower healthcare providers to tailor infection control protocols, resulting in enhanced patient outcomes. Furthermore, Dexur provides valuable insights into Possible Root Causes for Root Cause Analysis (RCA) of pathogen infections and recommends Corrective and Preventive Actions (CAPA) for these events. This comprehensive approach assists healthcare providers in overcoming challenges related to identifying major contributing factors and preventing future infections, ensuring a more effective and targeted response to the complexities associated with CLABSI infections.